2.08
BATS BZX Real-Time Price
As of 1:11pm ET
 -0.11 / -5.02%
Today’s Change
2.08
Today|||52-Week Range
6.19
-36.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$335.6M

Company Description

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.

Contact Information

Agenus, Inc.
3 Forbes Road
Lexington Massachusetts 02421
P:(781) 674-4400
Investor Relations:

Employees

Shareholders

Other institutional33.66%
Individual stakeholders21.47%
Mutual fund holders12.80%

Top Executives

Garo H. ArmenChairman & Chief Executive Officer
Christine M. KlaskinPrincipal Accounting Officer & VP-Finance
Alexander R. DuncanChief Technology Officer & Head-Research
Evan KearnsSecretary, Vice President & General Counsel
James GormanVP-Strategic Planning & Portfolio Management